Oral prednisolone in the treatment of esophageal stricture after esophageal surgery

Oral prednisolone in the treatment of esophageal stricture after esophageal surgery - Oral prednisolone in the treatment of esophageal stricture after esophageal surgery

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000020624

Enrollment

Registered

2016-01-18

Start date

2015-07-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal strictures

Interventions

Oral Prednisone for 12 weeks

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients who develop the severe esophageal strictures from 28 days after esophageal surgery

Exclusion criteria

Exclusion criteria: Pulmonary and cardiac disorders Liver and renal dysfunctions Allergic Pregnancy infectious disease Unsuitable condition

Design outcomes

Primary

Measure	Time frame
Safety and Success rate	—

Secondary

Measure	Time frame
The rate of re-strictures at 85 POD, dysphagia score, the session of the dilatation, body weight, biomarker, and endoscopic findings	—

Countries

Japan

Contacts

Public ContactShinichiro Kobayashi

Nagasaki University Graduate School of Biomedical Sciences Surgery

shinichirokobayashi@nagasaki-u.ac.jp+81958197316

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026